FARA – General Research Grant – LOI

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with Unit

Memorial Deadline: RGCS review not required for LOI submission

External Deadline: Saturday 1st, February 2020


Description

FARA Grant Program Priorities
Advancing understanding of neuroscience/ systems Understanding the neurodegeneration of FA and implications for therapies.
Advancing understanding of cardiac disease in FA Understanding the cardiomyopathy associated with FA and developing therapies to reduce the morbidity and mortality caused by cardiac disease in FA.
Advance drug discovery Highest priority in this category will be given to genetic, epigenetic, and protein approaches that target increasing frataxin levels. We also strongly consider high probability projects relating to therapeutics in pathways likely to affect the disease progression or disease symptoms.
Facilitate the drug development process and translational research FARA aims to support promising discoveries and to facilitate the rapid translation of those works into the clinic.

Highest priority in this category will be given to IND-enabling studies, as well as discovery and validation of clinical outcome measures and/or biomarkers.

Advance clinical research FARA supports efforts to enable effective clinical research. These include: natural history studies, discovery and validation of clinical outcome measures and/or biomarkers, identification of early (including pre-symptomatic) quantifiable clinical features, patient reported outcomes, investigator-initiated clinical trials, and evidence-based clinical treatment guidelines.

Highest priority in this category will be given to clinical research that utilizes or expands resources of the Collaborative Clinical Research Network in FA. As well, highest priority in this category will be given to continued development of biomarker discovery and validation, and early phase or pilot clinical studies.

All investigators interested in FA-related research are invited to submit a Letter of Intent (LOI) through our submission portal. For more information on how to apply for a FARA grant, click here. FARA particularly encourages junior investigators to submit LOIs.

Additional information can be found here.


Funding Sources

Friedreich's Ataxia Research Alliance



This opportunity was posted by: RGCS

Last modified: December 6, 2019